Quantcast
Last updated on April 17, 2014 at 15:50 EDT

Latest cancer detection Stories

2009-02-10 09:18:26

Eric Seibel, a UW mechanical engineering associate professor, and his colleagues have worked in collaboration with VisionGate, Inc., a privately held company in Gig Harbor, Wash., that holds the patents on the technology. The machine works by rotating the cell under the microscope lens and taking hundreds of pictures per rotation, and then digitally combining them to form a single 3-D image.The 3-D visualizations could lead to big advances in early cancer detection, since clinicians today...

2008-10-30 12:01:04

Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) and Konica Minolta Opto, Inc. (KMOT) of Tokyo, today announced that the two companies have extended an option to license and no shop agreement to co-develop certain of GT's non-invasive technologies. GT and KMOT expect to negotiate, and then sign, a definitive development agreement within approximately six months. A major focus of the agreement is expected to include jointly adapting GT's LightTouch(TM) non-invasive cervical cancer...

2008-09-30 12:00:48

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 30, 2008) - Perceptronix Medical Inc., a privately owned independent cytology laboratory specializing in early cancer detection tests, will present at the BioContact biopharmaceutical partnership symposium at Chateau Frontenac in Quebec City. The symposium will be held on October 2nd, 2008, at 2pm, Salle Petit Frontenac. Dr. Bojana Turic, President and CEO of Perceptronix will provide the Company overview and its' newest development and...

2008-09-26 09:00:40

Guided Therapeutics, a medical technology company, has completed its FDA pivotal clinical trial for its LightTouch non-invasive cervical cancer detection device. The GT LightTouch technology systematically and rapidly scans the cervix to identify cancers and pre-cancers painlessly and non-invasively by analyzing the wavelengths of light reflected from cervical tissue, the company said. Since the pivotal trial began, approximately 1,900 women have been tested to demonstrate the...

2008-09-25 09:00:54

Guided Therapeutics, Inc. (GT) (Pink Sheets: GTHP) today announced completion of its U.S. Food and Drug Administration (FDA) pivotal clinical trial for its LightTouch(TM) non-invasive cervical cancer detection device. The GT LightTouch technology systematically and rapidly scans the cervix to identify cancers and pre-cancers painlessly and non-invasively by analyzing the wavelengths of light reflected from cervical tissue. Since the pivotal trial began, approximately 1,900 women have...

2008-07-29 03:00:00

BERLIN and SEATTLE, July 29, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt Prime Standard:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer detection based on DNA methylation, today announced that it received a Rule 71(3) notification stating that the European Patent Office intends to grant a patent for Epigenomics' Septin 9 biomarker. This notification is equivalent to a "Notice of Allowance" by the United States Patent and...

2008-07-14 09:01:12

TUSTIN, Calif., July 14 /PRNewswire-FirstCall/ -- (http://www.amdl.com/) AMDL, Inc., a leading vertically integrated bio-pharmaceutical company with major operations in China and the US, announced that the AMDL-ELISA DR- 70(R) (FDP) test has been shown to be a useful test for the detection of cancer in clinical practice according to an independent study of 185 patients from the Medical Department II at the University Hospital in Frankfurt Germany. The results were published in the...

2008-07-09 18:00:35

SAN FRANCISCO, July 9 /PRNewswire/ -- Leading breast cancer researchers from across the country are convening in San Francisco July 10-11 for the first meeting of the Avon Foundation Breast Cancer Prevention Research Initiative. The two-day meeting, taking place at the Westin St. Francis, brings together researchers from leading institutions who are focused on the remarkable research in breast cancer biomarkers that has taken place over the last three years. The goal is to use the latest...

cc12d1e9838702b86b6f412bc3f22de4
2008-07-01 09:00:00

Scientists are improving breast cancer detection in women with the help of 3-D technology. The practice is most effective in women with breasts too dense for today's mammograms to give a clear picture. The Mayo Clinic in Rochester, Minnesota, is testing a new kind of breast camera that challenges the images of more expensive MRI exams now reserved for the most high-risk women. Radiologists will also wear 3-D glasses to help them determine risks.  Both technologies are still in the...

2008-06-30 03:02:50

SEATTLE and BERLIN, June 30, 2008 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), a molecular diagnostics company focusing on the development and commercialization of products for cancer detection based on DNA methylation, today announced the enrollment of the first subjects in the PRESEPT study. "We are excited that our PRESEPT study is now well under way as scheduled. PRESEPT is a unique endeavor: It is one of the largest colorectal cancer screening studies ever, and is the first to...